Interestingly, we show that these pancreatic adenocarcinoma cancer cells respond to cGAMP or cGAS expression in the tumor cells, demonstrating the efficacy of targeting the cGAS-STING pathway to rejuvenate antitumor response in these aggressive tumors. The gene discussed is CGAS; the disease is neoplasm.